Dapagliflozin ((2S)-1,2-propanediol, hydrate)
目录号: A17687
SGLT2 抑制剂
达格列净((2S)-1,2-丙二醇,水合物),一种用于治疗糖尿病(DM)的新型药物,是一种竞争性钠/葡萄糖共转运蛋白2(SGLT2)抑制剂,其作用机制是导致葡萄糖排泄到尿液中。
Discription | Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of drug used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine. |
---|
目录号 | A17687 |
---|---|
分子式 | C24H35ClO9 |
分子量 | 502.98 |
CAS号 | 960404-48-2 |
SMILES | O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O.C[C@H](O)CO.O |
其他名称 | BMS-512148 (2S)-1,2-propanediol, hydrate |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 92 mg/mL (182.91 mM) | |
Water | Insoluble | ||
Ethanol | 92 mg/mL (182.91 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.88 mL | 99.41 mL | 198.82 mL |
0.5 mM | 3.98 mL | 19.88 mL | 39.76 mL |
1 mM | 1.99 mL | 9.94 mL | 19.88 mL |
5 mM | 0.4 mL | 1.99 mL | 3.98 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2